To explore the role of the development of an effective host immune response in the different outcomes in these scenarios, we compared local/metastatic tumor growth in mice receiving the treatments described with that seen in similar mice but receiving not tumor cell vaccination but four courses of combination treatment with anti-VEGF and paclitaxel [14]. This evidence concerns the gene VEGFA and neoplasm.